Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"Virginia Commonwealth University" +contributor:("Michael McVoy"). Showing records 1 – 8 of 8 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Virginia Commonwealth University

1. Saccoccio, Frances. CMV vaccine development based on epithelial entry mediators UL128, UL130, UL131.

Degree: PhD, Microbiology & Immunology, 2011, Virginia Commonwealth University

 Congenital cytomegalovirus infection is the leading cause of sensorineural hearing loss in the U.S. CMV vaccines developed to date do not protect the majority of… (more)

Subjects/Keywords: cytomegalovirus; vaccine; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Saccoccio, F. (2011). CMV vaccine development based on epithelial entry mediators UL128, UL130, UL131. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/Y0B1-C043 ; https://scholarscompass.vcu.edu/etd/2507

Chicago Manual of Style (16th Edition):

Saccoccio, Frances. “CMV vaccine development based on epithelial entry mediators UL128, UL130, UL131.” 2011. Doctoral Dissertation, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/Y0B1-C043 ; https://scholarscompass.vcu.edu/etd/2507.

MLA Handbook (7th Edition):

Saccoccio, Frances. “CMV vaccine development based on epithelial entry mediators UL128, UL130, UL131.” 2011. Web. 15 Jan 2021.

Vancouver:

Saccoccio F. CMV vaccine development based on epithelial entry mediators UL128, UL130, UL131. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2011. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/Y0B1-C043 ; https://scholarscompass.vcu.edu/etd/2507.

Council of Science Editors:

Saccoccio F. CMV vaccine development based on epithelial entry mediators UL128, UL130, UL131. [Doctoral Dissertation]. Virginia Commonwealth University; 2011. Available from: https://doi.org/10.25772/Y0B1-C043 ; https://scholarscompass.vcu.edu/etd/2507


Virginia Commonwealth University

2. Alam, Zohaib. Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative.

Degree: MS, Microbiology & Immunology, 2013, Virginia Commonwealth University

 Cytomegalovirus (CMV) is a significant cause of mortality and morbidity in immunocompromised patients and an important cause of birth defects if acquired in utero. The… (more)

Subjects/Keywords: acid blue 129; atanyl blue PRL; CMV; cytomegalovirus; UL98; alkaline nuclease; anthraquinone; congenital infection; HCMV; UL54; UL97; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alam, Z. (2013). Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative. (Thesis). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/3A2C-0816 ; https://scholarscompass.vcu.edu/etd/3166

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alam, Zohaib. “Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative.” 2013. Thesis, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/3A2C-0816 ; https://scholarscompass.vcu.edu/etd/3166.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alam, Zohaib. “Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative.” 2013. Web. 15 Jan 2021.

Vancouver:

Alam Z. Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative. [Internet] [Thesis]. Virginia Commonwealth University; 2013. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/3A2C-0816 ; https://scholarscompass.vcu.edu/etd/3166.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alam Z. Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative. [Thesis]. Virginia Commonwealth University; 2013. Available from: https://doi.org/10.25772/3A2C-0816 ; https://scholarscompass.vcu.edu/etd/3166

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

3. Bhave, Sukhada. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.

Degree: MS, Microbiology & Immunology, 2012, Virginia Commonwealth University

 Cytomegalovirus (CMV) infections remain a significant problem in congenitally infected infants and immunocompromised individuals. Modest antiviral activities of currently approved drugs coupled with dose-limiting toxicities… (more)

Subjects/Keywords: cytomegalovirus; antivirals; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bhave, S. (2012). INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. (Thesis). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bhave, Sukhada. “INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.” 2012. Thesis, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bhave, Sukhada. “INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.” 2012. Web. 15 Jan 2021.

Vancouver:

Bhave S. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. [Internet] [Thesis]. Virginia Commonwealth University; 2012. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bhave S. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. [Thesis]. Virginia Commonwealth University; 2012. Available from: https://doi.org/10.25772/CNVY-TJ48 ; https://scholarscompass.vcu.edu/etd/2838

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

4. Mckiver, Bryan D. SND1-Targeted Gene Therapy for Hepatocellular Carcinoma.

Degree: MS, Molecular Biology and Genetics, 2018, Virginia Commonwealth University

  Staphylococcal nuclease and tudor-domain containing 1 (SND1) is an oncogene for a wide variety of cancers, including hepatocellular carcinoma (HCC). SND1 is a multifunctional… (more)

Subjects/Keywords: SND1; Hepatocellular Carcinoma; HCC; Gene Therapy; Tudor-SN; Genetics; Molecular Genetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mckiver, B. D. (2018). SND1-Targeted Gene Therapy for Hepatocellular Carcinoma. (Thesis). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/MSEN-5231 ; https://scholarscompass.vcu.edu/etd/5676

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mckiver, Bryan D. “SND1-Targeted Gene Therapy for Hepatocellular Carcinoma.” 2018. Thesis, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/MSEN-5231 ; https://scholarscompass.vcu.edu/etd/5676.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mckiver, Bryan D. “SND1-Targeted Gene Therapy for Hepatocellular Carcinoma.” 2018. Web. 15 Jan 2021.

Vancouver:

Mckiver BD. SND1-Targeted Gene Therapy for Hepatocellular Carcinoma. [Internet] [Thesis]. Virginia Commonwealth University; 2018. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/MSEN-5231 ; https://scholarscompass.vcu.edu/etd/5676.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mckiver BD. SND1-Targeted Gene Therapy for Hepatocellular Carcinoma. [Thesis]. Virginia Commonwealth University; 2018. Available from: https://doi.org/10.25772/MSEN-5231 ; https://scholarscompass.vcu.edu/etd/5676

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

5. ourahmane, amine. Discovery and Characterization of Cytomegalovirus Inhibitors using Reporter-based Antiviral Assays.

Degree: MS, Microbiology & Immunology, 2017, Virginia Commonwealth University

  ABSTRACT DISCOVERY AND CHARACTERIZATION OF CYTOMEGALOVIRUS INHIBITORS USING REPORTER-BASED ANTIVIRAL ASSAYS By Amine Ourahmane, MS A thesis submitted in partial fulfillment of the requirements… (more)

Commonwealth University, August 2017 Major Director: Michael McVoy, Ph.D. Professor, Department of… …requirements for the degree of Master of Science at Virginia Commonwealth University. Virginia… …Virginia Commonwealth University). TriplatinNC, DiplatinNC, and Pt(dien)Xan were… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

ourahmane, a. (2017). Discovery and Characterization of Cytomegalovirus Inhibitors using Reporter-based Antiviral Assays. (Thesis). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/9Y5G-A889 ; https://scholarscompass.vcu.edu/etd/5013

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

ourahmane, amine. “Discovery and Characterization of Cytomegalovirus Inhibitors using Reporter-based Antiviral Assays.” 2017. Thesis, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/9Y5G-A889 ; https://scholarscompass.vcu.edu/etd/5013.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

ourahmane, amine. “Discovery and Characterization of Cytomegalovirus Inhibitors using Reporter-based Antiviral Assays.” 2017. Web. 15 Jan 2021.

Vancouver:

ourahmane a. Discovery and Characterization of Cytomegalovirus Inhibitors using Reporter-based Antiviral Assays. [Internet] [Thesis]. Virginia Commonwealth University; 2017. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/9Y5G-A889 ; https://scholarscompass.vcu.edu/etd/5013.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

ourahmane a. Discovery and Characterization of Cytomegalovirus Inhibitors using Reporter-based Antiviral Assays. [Thesis]. Virginia Commonwealth University; 2017. Available from: https://doi.org/10.25772/9Y5G-A889 ; https://scholarscompass.vcu.edu/etd/5013

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

6. Meza, Benjamin. The Effect of Cell Type on the Efficacy of CMV Antiviral Drugs.

Degree: MS, Physiology, 2008, Virginia Commonwealth University

  Until recently, all in vitro drug susceptibility assays of cytomegalovirus (CMV) were performed in clinically irrelevant fibroblast cells. This study sought to test if… (more)

Subjects/Keywords: Cytomegalovirus; CMV; Antiviral; Drug; Ganciclovir; Maribavir; Fibroblast; Epithelial; ARPE-19; Retinitis; Life Sciences; Physiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meza, B. (2008). The Effect of Cell Type on the Efficacy of CMV Antiviral Drugs. (Thesis). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/YGHY-QY55 ; https://scholarscompass.vcu.edu/etd/1567

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Meza, Benjamin. “The Effect of Cell Type on the Efficacy of CMV Antiviral Drugs.” 2008. Thesis, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/YGHY-QY55 ; https://scholarscompass.vcu.edu/etd/1567.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Meza, Benjamin. “The Effect of Cell Type on the Efficacy of CMV Antiviral Drugs.” 2008. Web. 15 Jan 2021.

Vancouver:

Meza B. The Effect of Cell Type on the Efficacy of CMV Antiviral Drugs. [Internet] [Thesis]. Virginia Commonwealth University; 2008. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/YGHY-QY55 ; https://scholarscompass.vcu.edu/etd/1567.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Meza B. The Effect of Cell Type on the Efficacy of CMV Antiviral Drugs. [Thesis]. Virginia Commonwealth University; 2008. Available from: https://doi.org/10.25772/YGHY-QY55 ; https://scholarscompass.vcu.edu/etd/1567

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

7. Sauer, Anne. Inhibition of cytomegalovirus genome maturation by the halogenated benzimidazoles.

Degree: PhD, Microbiology & Immunology, 2010, Virginia Commonwealth University

 Current FDA approved anti-cytomegalovirus antivirals are ganciclovir, foscarnet, and cidofovir. These drugs target the viral polymerase to inhibit DNA synthesis. Halogenated benzimidazoles target a step… (more)

Subjects/Keywords: Genome Maturation; GPCMV; HCMV; Halogenated Benzimidazoles; Monomer; Terminase; Viral Packaging and Cleavage; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sauer, A. (2010). Inhibition of cytomegalovirus genome maturation by the halogenated benzimidazoles. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/7P7Y-9897 ; https://scholarscompass.vcu.edu/etd/2453

Chicago Manual of Style (16th Edition):

Sauer, Anne. “Inhibition of cytomegalovirus genome maturation by the halogenated benzimidazoles.” 2010. Doctoral Dissertation, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/7P7Y-9897 ; https://scholarscompass.vcu.edu/etd/2453.

MLA Handbook (7th Edition):

Sauer, Anne. “Inhibition of cytomegalovirus genome maturation by the halogenated benzimidazoles.” 2010. Web. 15 Jan 2021.

Vancouver:

Sauer A. Inhibition of cytomegalovirus genome maturation by the halogenated benzimidazoles. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2010. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/7P7Y-9897 ; https://scholarscompass.vcu.edu/etd/2453.

Council of Science Editors:

Sauer A. Inhibition of cytomegalovirus genome maturation by the halogenated benzimidazoles. [Doctoral Dissertation]. Virginia Commonwealth University; 2010. Available from: https://doi.org/10.25772/7P7Y-9897 ; https://scholarscompass.vcu.edu/etd/2453


Virginia Commonwealth University

8. Harrison, Jenica. The Role of Acanthamoeba culbertsoni Serine Proteases in Abating Microglial-Like Cell Cytokines and Chemokines.

Degree: PhD, Microbiology & Immunology, 2009, Virginia Commonwealth University

 Acanthamoeba culbertsoni is an opportunistic free-living amoeba that is causative of granulomatous amoebic encephalitis (GAE), a chronic and often fatal central nervous system (CNS) disease… (more)

Subjects/Keywords: Acanthamoeba; Microglia; Proteases; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harrison, J. (2009). The Role of Acanthamoeba culbertsoni Serine Proteases in Abating Microglial-Like Cell Cytokines and Chemokines. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/BCN2-NT22 ; https://scholarscompass.vcu.edu/etd/1764

Chicago Manual of Style (16th Edition):

Harrison, Jenica. “The Role of Acanthamoeba culbertsoni Serine Proteases in Abating Microglial-Like Cell Cytokines and Chemokines.” 2009. Doctoral Dissertation, Virginia Commonwealth University. Accessed January 15, 2021. https://doi.org/10.25772/BCN2-NT22 ; https://scholarscompass.vcu.edu/etd/1764.

MLA Handbook (7th Edition):

Harrison, Jenica. “The Role of Acanthamoeba culbertsoni Serine Proteases in Abating Microglial-Like Cell Cytokines and Chemokines.” 2009. Web. 15 Jan 2021.

Vancouver:

Harrison J. The Role of Acanthamoeba culbertsoni Serine Proteases in Abating Microglial-Like Cell Cytokines and Chemokines. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2009. [cited 2021 Jan 15]. Available from: https://doi.org/10.25772/BCN2-NT22 ; https://scholarscompass.vcu.edu/etd/1764.

Council of Science Editors:

Harrison J. The Role of Acanthamoeba culbertsoni Serine Proteases in Abating Microglial-Like Cell Cytokines and Chemokines. [Doctoral Dissertation]. Virginia Commonwealth University; 2009. Available from: https://doi.org/10.25772/BCN2-NT22 ; https://scholarscompass.vcu.edu/etd/1764

.